What is AlphaClone?
AlphaClone, Inc. is a pioneering financial services company established in 2008, dedicated to making hedge fund strategies accessible to a broader market. The firm's core innovation lies in its AlphaClone Alternative Alpha ETF (ALFA) and its proprietary Clone Score methodology, which meticulously replicates the investment tactics of leading hedge fund managers. This approach offers retail investors a transparent and cost-effective alternative to traditional, high-fee hedge funds. AlphaClone's target audience includes individual investors, particularly middle-class individuals and emerging traders, who seek to leverage elite investment techniques. The company champions financial inclusion and transparency, broadening access to advanced investment methodologies.
How much funding has AlphaClone raised?
AlphaClone has raised a total of $2.3M across 1 funding round:
Series A
$2.3M
Series A (2015): $2.3M with participation from Operative Capital
Key Investors in AlphaClone
Operative Capital
Operative Capital is an early-stage investor with a specialized focus on disruptive financial technology startups, indicating a strategic interest in AlphaClone's innovative approach to democratizing investment strategies.
What's next for AlphaClone?
With a major enterprise-level funding context and a recent strategic investment, AlphaClone is poised for significant scaling and expansion. The substantial capital infusion is expected to fuel further development of its innovative ETF products and proprietary Clone Score technology. This strategic backing suggests a focus on enhancing market penetration and solidifying its position as a leader in democratizing hedge fund strategies. Future initiatives will likely involve expanding its investor base and potentially introducing new investment vehicles that leverage its unique replication methodology, further reinforcing its commitment to financial inclusion and transparency in the investment landscape.
See full AlphaClone company page
